Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma

Antiantiogenic therapy with bevacizumab in recurrent glioblastoma is currently understood to both reduce microvascular density and to prune abnormal tumor microvessels. Microvascular pruning and the resulting vascular normalization are hypothesized to reduce tumor hypoxia and increase supply of syst...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cereb Blood Flow Metab
Autori principali: Bonekamp, David, Mouridsen, Kim, Radbruch, Alexander, Kurz, Felix T, Eidel, Oliver, Wick, Antje, Schlemmer, Heinz-Peter, Wick, Wolfgang, Bendszus, Martin, Østergaard, Leif, Kickingereder, Philipp
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2016
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5381446/
https://ncbi.nlm.nih.gov/pubmed/26861817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0271678X16630322
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi